Mascitelli Justin R, Lawton Michael T, Hendricks Benjamin K, Hardigan Trevor A, Yoon James S, Yaeger Kurt A, Kellner Christopher P, De Leacy Reade A, Fifi Johanna T, Bederson Joshua B, Albuquerque Felipe C, Ducruet Andrew F, Birnbaum Lee A, Caron Jean Louis R, Rodriguez Pavel, Mocco J
1Department of Neurosurgery, University of Texas Health Science Center at San Antonio, Texas.
2Department of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona.
J Neurosurg. 2021 Nov 5;137(1):87-94. doi: 10.3171/2021.7.JNS211323. Print 2022 Jul 1.
Randomized controlled trials have demonstrated the superiority of endovascular therapy (EVT) compared to microsurgery (MS) for ruptured aneurysms suitable for treatment or when therapy is broadly offered to all presenting aneurysms; however, wide neck aneurysms (WNAs) are a challenging subset that require more advanced techniques and warrant further investigation. Herein, the authors sought to investigate a prospective, multicenter WNA registry using rigorous outcome assessments and compare EVT and MS using propensity score analysis (PSA).
Untreated, ruptured, saccular WNAs were included in the analysis. A WNA was defined as having a neck ≥ 4 mm or a dome/neck ratio (DNR) < 2. The primary outcome was the modified Rankin Scale (mRS) score at 1 year posttreatment, as assessed by blinded research nurses (good outcome: mRS scores 0-2) and compared using PSA.
The analysis included 87 ruptured aneurysms: 55 in the EVT cohort and 32 in the MS cohort. Demographics were similar in the two cohorts, including Hunt and Hess grade (p = 0.144) and modified Fisher grade (p = 0.475). WNA type inclusion criteria were similar in the two cohorts, with the most common type having a DNR < 2 (EVT 60.0% vs MS 62.5%). More anterior communicating artery aneurysms (27.3% vs 18.8%) and posterior circulation aneurysms (18.2% vs 0.0%) were treated with EVT, whereas more middle cerebral artery aneurysms were treated with MS (34.4% vs 18.2%, p = 0.025). Within the EVT cohort, 43.6% underwent stand-alone coiling, 50.9% balloon-assisted coiling, 3.6% stent-assisted coiling, and 1.8% flow diversion. The 1-year mRS score was assessed in 81 patients (93.1%), and the primary outcome demonstrated no increased risk for a poor outcome with MS compared to EVT (OR 0.43, 95% CI 0.13-1.45, p = 0.177). The durability of MS was higher, as evidenced by retreatment rates of 12.7% and 0% for EVT and MS, respectively (p = 0.04).
EVT and MS had similar clinical outcomes at 1 year following ruptured WNA treatment. Because of their challenging anatomy, WNAs may represent a population in which EVT's previously demonstrated superiority for ruptured aneurysm treatment is less relevant. Further investigation into the treatment of ruptured WNAs is warranted.
随机对照试验已证明,对于适合治疗的破裂动脉瘤或当对所有就诊动脉瘤广泛提供治疗时,血管内治疗(EVT)优于显微手术(MS);然而,宽颈动脉瘤(WNA)是一个具有挑战性的子集,需要更先进的技术,值得进一步研究。在此,作者试图通过严格的结果评估来研究一个前瞻性、多中心的WNA登记系统,并使用倾向评分分析(PSA)比较EVT和MS。
未治疗的、破裂的囊状WNA纳入分析。WNA定义为颈部≥4mm或瘤顶/颈部比值(DNR)<2。主要结局是治疗后1年的改良Rankin量表(mRS)评分,由不知情的研究护士评估(良好结局:mRS评分0 - 2),并使用PSA进行比较。
分析包括87个破裂动脉瘤:EVT队列55个,MS队列32个。两个队列的人口统计学特征相似,包括Hunt和Hess分级(p = 0.144)和改良Fisher分级(p = 0.475)。两个队列的WNA类型纳入标准相似,最常见类型的DNR<2(EVT为60.0%,MS为62.5%)。EVT治疗的前交通动脉瘤(27.3%对18.8%)和后循环动脉瘤(18.2%对0.0%)更多,而MS治疗的大脑中动脉动脉瘤更多(34.4%对18.2%,p = 0.025)。在EVT队列中,43.6%接受单纯弹簧圈栓塞,50.9%接受球囊辅助弹簧圈栓塞,3.6%接受支架辅助弹簧圈栓塞,1.8%接受血流导向治疗。81例患者(93.1%)评估了1年mRS评分,主要结局显示与EVT相比,MS导致不良结局的风险没有增加(OR 0.43,95%CI 0.13 - 1.45,p = 0.177)。MS的持久性更高,EVT和MS的再治疗率分别为12.7%和0%,证明了这一点(p = 0.04)。
破裂WNA治疗后1年,EVT和MS的临床结局相似。由于其具有挑战性的解剖结构,WNA可能代表了一个群体,在该群体中,EVT先前在破裂动脉瘤治疗中所显示的优势相关性较低。对破裂WNA的治疗进行进一步研究是必要的。